Day One to Present at the 43rd Annual J.P. Morgan Healthcare Conference
BRISBANE, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical...
Healthcare
BrightInsight Expands Global Digital Partnership with Sanofi to Build Drug Companion Apps for its Major Specialty Therapies
Following the success of the MyWay app in the US and Germany, the partners will expand brand-oriented digital health companion...
Scienture Holdings, Inc. Announces Participation in The Microcap Conference 2025
TAMPA, FL, Dec. 17, 2024 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (the “Company”) (NASDAQ: SCNX), a specialty pharma company with...
Avalyn to Present at the 43rd Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inhaled...
Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia
FDA is expected to assign a Prescription Drug User Fee Act (PDUFA) target action date and announce whether Priority Review...
aTyr Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Dec. 17, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in...
MediWound to Host Virtual Key Opinion Leader Event to Discuss EscharEx® Phase III VALUE Study in Venous Leg Ulcers and Its Commercial Opportunity on January 8, 2025
YAVNE, Israel, Dec. 17, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for...
RTI Surgical Transforms into Evergen, a Leading CDMO in Regenerative Medicine
ALACHUA, Fla., December 17, 2024 – RTI Surgical ("the Company"), a leading CDMO pushing the boundaries of innovation and tissue...
Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease
Teva hosting investor call today at 8:00 a.m. ET (U.S.)Primary endpoints met in ulcerative colitis (UC) and Crohn’s disease (CD),...
Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease
Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease Primary endpoints met in ulcerative colitis...
EYLEA HD® (aflibercept) Injection 8 mg Phase 3 Trial Meets Primary Endpoint Showing Improved Vision with Extended Dosing Intervals in Patients with Macular Edema following Retinal Vein Occlusion
EYLEA HD demonstrated non-inferior vision gains with an every 8-week dosing regimen compared to EYLEA® (aflibercept) Injection 2 mg dosed...
Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab
NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology...
Scott Burger Appointed as CEO of AngioInsight, Inc.
Momentum Building with Novel Cardiology AI SolutionMINNETONKA, Minn.--(BUSINESS WIRE)--#CVD--AngioInsight, Inc., an innovator in medical imaging technologies, is pleased to announce...
Fangzhou Inc. Recognized as an “Outstanding Enterprise in Digital Intelligence” by Analysys Star
HANGZHOU, China, Dec. 17, 2024 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, was recognized...
myTomorrows Expands Clinical Trial Search with ISRCTN Registry to Deliver Comprehensive Overview of Options
The myTomorrows platform now also features embedded AI eligibility checking and usability improvements, further streamlining the clinical trial and Expanded...
Exploring Space and Neurotherapeutics at the 2025 Ultrasound Event: A Journey into the Future of Medical Ultrasound
ORLANDO, Fla., Dec. 16, 2024 /PRNewswire/ -- The 2025 AIUM Annual Convention, hosted by the American Institute of Ultrasound in...
Black Book Research Announces Complimentary Access to the 2025 Global Healthcare IT Resource Directory and Adoption Report
NEW YORK CITY, NEW YORK / ACCESSWIRE / December 16, 2024 / Black Book Research announces the release of the...
Cloud DX Completes First Stage of Restructuring Process
KITCHENER, ON / ACCESSWIRE / December 16, 2024 / Cloud DX Inc. ("Cloud DX") (TSXV:CDX)(OTCQB:CDXFF) today reports the sale of...
Axtria Unveils New US and Global Incentive Compensation Benchmarking Studies: Insights That Drive Life Sciences Success
Key Trends, Metrics, and Best Practices Unveiled to Optimize Incentive Strategies and Drive Performance in Life Sciences BERKELEY HEIGHTS, N.J.,...
Trella Health Launches Special Report on Home Health Accessibility for Medicare Fee-for-Service (FFS) Beneficiaries
An analysis of the key trends shaping access to care for Medicare patients ATLANTA, Dec. 16, 2024 /PRNewswire/ -- Trella...